关注
Armando Andres Roca Suarez
Armando Andres Roca Suarez
Centre de Recherche en Cancérologie - Lyon (CRCL) - UMR 1052
在 inserm.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
HCV-induced epigenetic changes associated with liver cancer risk persist after sustained virologic response
N Hamdane, F Jühling, E Crouchet, H El Saghire, C Thumann, MA Oudot, ...
Gastroenterology 156 (8), 2313-2329. e7, 2019
2302019
Viral manipulation of STAT3: Evade, exploit, and injure
AA Roca Suarez, N Van Renne, TF Baumert, J Lupberger
PLoS pathogens 14 (3), e1006839, 2018
1092018
Combined analysis of metabolomes, proteomes, and transcriptomes of hepatitis C virus–infected cells and liver to identify pathways associated with disease development
J Lupberger, T Croonenborghs, AAR Suarez, N Van Renne, F Jühling, ...
Gastroenterology 157 (2), 537-551. e9, 2019
1072019
Hepatitis C virus and hepatocellular carcinoma: when the host loses its grip
K Goto, AA Roca Suarez, F Wrensch, TF Baumert, J Lupberger
International journal of molecular sciences 21 (9), 3057, 2020
792020
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
F Jühling, N Hamdane, E Crouchet, S Li, H El Saghire, A Mukherji, ...
Gut 70 (1), 157-169, 2021
722021
Tight junction proteins and the biology of hepatobiliary disease
N Roehlen, AA Roca Suarez, H El Saghire, A Saviano, C Schuster, ...
International journal of molecular sciences 21 (3), 825, 2020
662020
miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis
N Van Renne, AAR Suarez, FHT Duong, C Gondeau, D Calabrese, ...
Gut 67 (5), 953-962, 2018
652018
HBV 2021: New therapeutic strategies against an old foe
AA Roca Suarez, B Testoni, F Zoulim
Liver International 41, 15-23, 2021
472021
Oncogenic signaling induced by HCV infection
A Virzì, AA Roca Suarez, TF Baumert, J Lupberger
Viruses 10 (10), 538, 2018
312018
Stromal and immune drivers of hepatocarcinogenesis
A Saviano, N Roehlen, A Virzì, AA Roca Suarez, Y Hoshida, J Lupberger, ...
Hepatocellular carcinoma: Translational precision medicine approaches, 317-331, 2019
152019
Hepatitis B virus targets lipid transport pathways to infect hepatocytes
K Esser, X Cheng, JM Wettengel, J Lucifora, L Hansen-Palmus, K Austen, ...
Cellular and Molecular Gastroenterology and Hepatology 16 (2), 201-221, 2023
112023
Nucleic Acid-Induced Signaling in Chronic Viral Liver Disease
AA Roca Suarez, B Testoni, TF Baumert, J Lupberger
Frontiers in Immunology 11, 624034, 2021
112021
Rewiring host signaling: hepatitis C virus in liver pathogenesis
A Virzì, AAR Suarez, TF Baumert, J Lupberger
Cold Spring Harbor Perspectives in Medicine 10 (1), a037366, 2020
102020
Evaluation of the HBV liver reservoir with fine needle Aspirates
B Testoni, AAR Suarez, A Battisti, ML Plissonnier, M Heil, T Fontanges, ...
JHEP Reports 5 (10), 100841, 2023
72023
Beyond viral dependence: The pathological consequences of HCV-induced EGF signaling
AAR Suarez, TF Baumert, J Lupberger
Journal of hepatology 69 (3), 564-566, 2018
72018
Emerging anti‐HDV drugs and HBV cure strategies with anti‐HDV activity
AA Roca Suarez, E Batbold, B Bartosch, N Dashdorj, B Testoni, F Zoulim
Liver International 43, 87-95, 2023
32023
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
F Juhling, N Hamdane, E Crouchet, S Li, H El Saghire, A Mukherji, ...
Gut 70 (1), 157-169, 2021
32021
TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism
AAR Suarez, ML Plissonnier, X Grand, M Michelet, G Giraud, ...
Gut, 2024
22024
Opportunities and challenges for hepatitis B cure
AAR Suarez, F Zoulim
eGastroenterology 1 (2), 2023
12023
miR-135a-5p-mediated downregulation of protein-tyrosine phosphatase delta is a candidate driver of HCV-associated hepatocarcinogenesis
N Van Renne, AAR Suarez, FHT Duong, C Gondeau, D Calabrese, ...
12016
系统目前无法执行此操作,请稍后再试。
文章 1–20